Related Experiment Videos
Impaired oxidative burst does not affect human monocyte tumoricidal activity
Journal of Immunology (Baltimore, Md. : 1950)
|March 1, 1985
Summary
Monocytes can kill tumor cells even without an oxidative burst. This study found that reactive oxygen metabolites are not the main drivers of this monocyte tumoricidal activity.
Area of Science:
- Immunology
- Cell Biology
Background:
- Human peripheral blood monocytes exhibit selective lysis of neoplastic cells.
- The oxidative burst, involving hydrogen peroxide and superoxide anion, has been hypothesized to mediate this monocyte tumoricidal activity.
Purpose of the Study:
- To investigate the role of the oxidative burst in mediating monocyte-mediated tumor cell lysis.
Main Methods:
- Studied two patients with chronic granulomatous disease (CGD) with impaired oxidative burst function.
- Assessed monocyte tumoricidal activity using 51Cr-release assays against K562, WEHI-164, and Daudi target cells.
- Evaluated tumoricidal activity of oxygen-deprived normal donor monocytes.
Main Results:
- A CGD patient with no detectable oxidative burst showed high monocyte tumoricidal activity against K562 and Actinomycin D-treated WEHI-164 cells.
- Another CGD patient with a reduced oxidative burst (15% of normal) efficiently killed Daudi targets.
- Normal monocytes, when deprived of oxygen and unable to produce an oxidative burst, still exhibited normal tumoricidal activity.
Conclusions:
- Reactive oxygen metabolites are not the primary mediators of tumor cell lysis by human peripheral blood monocytes.
- Monocyte tumoricidal activity can occur independently of a significant oxidative burst.